These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 7251666)

  • 1. Cell polarity: an examination of its behavioral expression and its consequences for polymorphonuclear leukocyte chemotaxis.
    Zigmond SH; Levitsky HI; Kreel BJ
    J Cell Biol; 1981 Jun; 89(3):585-92. PubMed ID: 7251666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors.
    Zigmond SH
    J Cell Biol; 1977 Nov; 75(2 Pt 1):606-16. PubMed ID: 264125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ionic basis of chemotaxis. Separate cation requirements for neutrophil orientation and locomotion in a gradient of chemotactic peptide.
    Marasco WA; Becker EL; Oliver JM
    Am J Pathol; 1980 Mar; 98(3):749-68. PubMed ID: 6767408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphonuclear leucocyte chemotaxis: detection of the gradient and development of cell polarity.
    Zigmond SH
    Ciba Found Symp; 1980; 71():299-311. PubMed ID: 6989568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human polymorphonuclear leukocytes respond to waves of chemoattractant, like Dictyostelium.
    Geiger J; Wessels D; Soll DR
    Cell Motil Cytoskeleton; 2003 Sep; 56(1):27-44. PubMed ID: 12905529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of chemotactic activity and 64 kD protein phosphorylation for human polymorphonuclear leukocytes in N-terminus of the chemotactic protein LUCT/IL-8.
    Suzuki K; Koshio O; Ishida-Okawara A; Shibata M; Yamakawa Y; Tagawa M; Ota H; Kuramoto A; Mizuno S
    Biochem Biophys Res Commun; 1989 Sep; 163(3):1298-305. PubMed ID: 2675839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures.
    Fearon DT; Collins LA
    J Immunol; 1983 Jan; 130(1):370-5. PubMed ID: 6847888
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of the myosin inhibitor 2,3-butanedione monoxime (BDM) on cell shape, locomotion and fluid pinocytosis in human polymorphonuclear leucocytes.
    Urwyler N; Eggli P; Keller HU
    Cell Biol Int; 2000; 24(12):863-70. PubMed ID: 11114235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific modulation of the intracellular pH of rabbit neutrophils by chemotactic factors.
    Molski TF; Naccache PH; Volpi M; Wolpert LM; Sha'afi RI
    Biochem Biophys Res Commun; 1980 May; 94(2):508-14. PubMed ID: 7396914
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotactically-induced redistribution of CD43 as related to polarity and locomotion of human polymorphonuclear leucocytes.
    Dehghani Zadeh A; Seveau S; Halbwachs-Mecarelli L; Keller HU
    Biol Cell; 2003 Jul; 95(5):265-73. PubMed ID: 12941524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Video analysis of chemotactic locomotion of stored human polymorphonuclear leukocytes.
    Burton JL; Law P; Bank HL
    Cell Motil Cytoskeleton; 1986; 6(5):485-91. PubMed ID: 3791425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
    Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
    Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of chemotaxis of polymorphonuclear leukocytes in vitro. The problems of the control of gradients of chemotactic factors, of the control of the cells and of the separation of chemotaxis from chemokinesis.
    Bignold LP
    J Immunol Methods; 1988 Apr; 108(1-2):1-18. PubMed ID: 3280683
    [No Abstract]   [Full Text] [Related]  

  • 14. Neutrophil leucocyte chemotaxis: a simplified assay for measuring polarizing responses to chemotactic factors.
    Haston WS; Shields JM
    J Immunol Methods; 1985 Aug; 81(2):229-37. PubMed ID: 4020151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of chemotactic peptide receptor modulation for leukocyte orientation.
    Zigmond SH
    J Cell Biol; 1981 Mar; 88(3):644-7. PubMed ID: 6260816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensory adaptation of leukocytes to chemotactic peptides.
    Zigmond SH; Sullivan SJ
    J Cell Biol; 1979 Aug; 82(2):517-27. PubMed ID: 479314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotactic efficiency of various chemoattractants for polymorphonuclear leukocytes in inflammatory acne vulgaris.
    Knop J; Bossecker T; Kövary PM
    Arch Dermatol Res; 1982; 274(3-4):267-75. PubMed ID: 6219635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic manipulation of leukocyte chemotaxis. Present knowledge and future trends.
    Snyderman R
    Am J Med; 1983 Oct; 75(4B):10-8. PubMed ID: 6314812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotactically directed redistribution of alpha-actinin precedes morphological polarization and reversal of polarity in human polymorphonuclear leucocytes (PMNs).
    Zadeh AD; Keller H
    Eur J Cell Biol; 2003 Feb; 82(2):93-6. PubMed ID: 12647935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotactic deactivation of human neutrophils: relationship to loss of cytotaxin receptor function and temporal nature of the phenomenon.
    Nelson RD; Fiegel VD; Herron MJ; Simmons RL
    J Reticuloendothel Soc; 1980 Sep; 28(3):285-94. PubMed ID: 7411541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.